Cold Mice Skewing Data?

Another study finds that housing experimental mice at lower-than-optimal temperatures may alter research outcomes, this time with regard to inflammation and diet.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, RAMAMice held at typical laboratory temperatures (about 22° C) and fed a high-fat diet to promote obesity and a high-cholesterol diet to encourage atherosclerosis suffer less inflammation than mice fed the same diets but held at 30° C, which is closer to the animal’s optimum operating temperature. The findings, which were published in Cell Metabolism earlier this month (November 5), add to a growing body of literature that highlights important—but often unaccounted for—effects of low temperatures in mouse studies that seek to approximate human biology.

Mice housed at 20-26° C—which is below their “thermoneutral zone” of 30-32° C and is the convention for animals involved in biomedical studies—expend more energy than they normally would and exhibit symptoms of physiological stress, such as elevated heart rates, faster weight gain, higher respiration rates, and increased blood lipids. But the new study, conducted by an international team of researchers, suggests that inflammation may also differ in mice that are housed below their thermoneutral zone. Ajay Chawla, a molecular physiologist at the University of California, San Francisco, told Science News that the research serves as yet another example of an aspect of mouse physiology that researchers could be missing in mice that are held in temperatures that are too low. “It’s one thing to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies